Related Experiment Video

Updated: Jul 5, 2026

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies
07:59

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

Chagas disease cardiomyopathy: current concepts of an old disease

Angelina M B Bilate1, Edecio Cunha-Neto

  • 1Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, NY 10016, USA. bilate@saturn.med.nyu.edu

Revista Do Instituto De Medicina Tropical De Sao Paulo
|May 20, 2008
PubMed

Insights

Chagas disease cardiomyopathy (CCC) involves both parasite and autoimmune responses, leading to heart inflammation and damage. This review summarizes recent research on the immunopathogenesis of CCC.

Area of Science:

  • Immunology
  • Cardiology
  • Infectious Diseases

Background:

  • Chagas disease, caused by *T. cruzi*, affects millions in Latin America.
  • Chronic infection leads to Chagas disease cardiomyopathy (CCC) in 30% of individuals.
  • CCC is characterized by chronic inflammation and heart lesions.

Purpose of the Study:

  • To review recent advances in understanding the immunopathogenesis of Chagas disease cardiomyopathy.
  • To explore the roles of parasite-driven and autoimmune responses in CCC development.

Main Methods:

  • Review of current literature on Chagas disease cardiomyopathy.
  • Analysis of data from murine models and human studies.
  • Focus on immune responses, inflammatory cytokines, and chemokines.

Main Results:

  • Evidence suggests both parasite-driven and autoimmune mechanisms contribute to CCC.
  • Inflammatory cytokines and chemokines are implicated in heart lesion formation.
  • Understanding these pathways is crucial for therapeutic strategies.

Conclusions:

  • The immunopathogenesis of CCC is complex, involving multiple immune pathways.
  • Further research into these mechanisms can guide the development of treatments for Chagas disease.
  • Targeting immune responses may mitigate cardiac damage in Chagas disease patients.

More Related Videos

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model09:23

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model

Published on: July 29, 2012

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...